Synthetic organic

Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM, modestly potent to Abl, TrkA, c-RET and FGFR1, and less potent to Lck, VEGFR2/3, c-Kit, CDK2, etc.

Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM, modestly potent to Abl, TrkA, c-RET and FGFR1, and less potent to Lck, VEGFR2/3, c-Kit, CDK2, etc.

DAPI.

DAPI.

dapiprazole.

dapiprazole.

DAPK inhibitor 13.

DAPK inhibitor 13.

InformationDaprodustat (GSK1278863) Daprodustat (GSK1278863) is an orally administered hypoxia-inducible factor-prolyl hydroxylase ( HIF-PH ) inhibitor. Phase 2.TargetsHIF-PHIn vitroGSK1278863 induces an effective EPO response and stimulates non-EPO

InformationDaprodustat (GSK1278863) Daprodustat (GSK1278863) is an orally administered hypoxia-inducible factor-prolyl hydroxylase ( HIF-PH ) inhibitor. Phase 2.TargetsHIF-PHIn vitroGSK1278863 induces an effective EPO response and stimulates non-EPO

InformationDaprodustat (GSK1278863) Daprodustat (GSK1278863) is an orally administered hypoxia-inducible factor-prolyl hydroxylase ( HIF-PH ) inhibitor. Phase 2.TargetsHIF-PHIn vitroGSK1278863 induces an effective EPO response and stimulates non-EPO

InformationDaprodustat (GSK1278863) Daprodustat (GSK1278863) is an orally administered hypoxia-inducible factor-prolyl hydroxylase ( HIF-PH ) inhibitor. Phase 2.TargetsHIF-PHIn vitroGSK1278863 induces an effective EPO response and stimulates non-EPO